Six-month Coenzyme Q10 Supplementation Improves Liver and Cardiovascular Function
Study Overview
A clinical trial assessed the effects of coenzyme-Q10 supplementation on patients with Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD).
Results
After six months, patients receiving coenzyme-Q10 showed significant improvements in various measures, including reduced liver steatosis, improved endothelial and vascular function, and enhanced myocardial function.
Practical Solutions
These findings suggest that high-dose coenzyme-Q10 supplementation can lead to notable improvements in micro- and macro-vasculature function, offering potential benefits for patients with MASLD.
Value
This study highlights the potential value of coenzyme-Q10 supplementation in improving liver and cardiovascular function in patients with MASLD, providing insights for clinical practice and patient care.
